Megatrends

The most influential Megatrends set to shape the world through 2030, identified by Euromonitor International, help businesses better anticipate market developments and lead change for their industries.

Analgesics in Sweden

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

PROSPECTS

The ban on acetaminophen tablets in grocery retailers

Since the 2015 ban on sales of acetaminophen tablets in grocery retailers in Sweden, channel distribution was affected, with decreasing sales through grocery retailers. One could reasonably expect that overall value sales of acetaminophen would go down, but the category displayed slight growth in 2018.

A decline is seen by topical analgesics/anaesthetic

The ageing of the Swedish population has increased sales of medication that focus on solving aches and pains and other issues experienced by the elderly. However, in 2017 and 2018 topical analgesics/anaesthetic struggled to achieve growth; instead seeing a small decline.

Swedes tend not to purchase generics

In Sweden, the rise in generics in analgesics subsided in 2018, and seemed to be stagnating. The overall response from large companies of offering lower prices is one explanation; however, the price pressure on such products is quite high and the mark-ups are slim.

COMPETITIVE LANDSCAPE

Brand loyalty determines value shares

Unlike the market for prescription medicines, pharmacies in Sweden must suggest the lowest-priced OTC products. Hence, branding becomes more important, and a large proportion of the different categories are dominated by one or two large brands.

Protection in the coming price war in analgesics

With the rising success of internet pharmacy apotea.se in Sweden, most categories, but especially analgesics, have seen increased price competition, as pharmacies tend to harmonise their internet retailing prices but keep store prices unchanged.

Internet retailing could be next to see regulatory limits on sales

The prospects for analgesics are poor, as it is a highly mature category with little room for innovation, due to the high cost of developing new drugs. Furthermore, the regulatory environment is always sensitive to new findings and restrictions on purchases due to the risk of overconsumption.

Files are delivered directly into your account within a few minutes of purchase.